| 英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
| Lasmiditan |
拉米地坦 |
439239-90-4 |
詳細(xì)
|
| Bay-876 |
BAY-876 |
1799753-84-6 |
詳細(xì)
|
| ABBV-075 |
米維布塞 |
1445993-26-9 |
詳細(xì)
|
| GDC-0084 |
GDC-0084 |
1382979-44-3 |
詳細(xì)
|
| Acebilustat |
阿西魯司特 |
943764-99-6 |
詳細(xì)
|
| GSK-2256098 |
GSK-2256098 |
1224887-10-8 |
詳細(xì)
|
| BP-1-102 |
4-(N-(4-環(huán)己基芐基)-2-((2,3,4,5,6-五氟-N-甲苯基)磺酰氨基)乙酰氨基)-2-羥基苯甲酸 |
1334493-07-0 |
詳細(xì)
|
| RAF-709 |
化合物RAF709 |
1628838-42-5 |
詳細(xì)
|
| CP-21R7 |
GSK-3Β抑制劑(CP21R7) |
125314-13-8 |
詳細(xì)
|
| SH5-07 (SH-5-07) |
1456632-41-9 |
1456632-41-9 |
詳細(xì)
|
| AMG-3969 |
AMG-3969 |
1361224-53-4 |
詳細(xì)
|
| SUN11602 |
化合物SUN 11602 |
704869-38-5 |
詳細(xì)
|
| GS-9620 |
GS9620 |
1228585-88-3 |
詳細(xì)
|
| GNE-3511 |
化合物GNE-3511 |
1496581-76-0 |
詳細(xì)
|
| Lasmiditan hemisuccinate |
琥珀酸拉斯米迪坦 |
439239-92-6 |
詳細(xì)
|
| Lasmiditan hydrochloride |
613677-28-4 |
613677-28-4 |
詳細(xì)
|
| Grapiprant |
GRAPIPRANT |
415903-37-6 |
詳細(xì)
|
| GSK2982772 |
GSK2982772 |
1622848-92-3 |
詳細(xì)
|
| Pexidartinib (PLX3397) |
培西達(dá)替尼 |
1029044-16-3 |
詳細(xì)
|
| Pexidartinib (PLX3397) HCl |
|
|
詳細(xì)
|
| UK-371804 (Urokinase inhitibor 1） |
化合物UK371804 |
256477-09-5 |
詳細(xì)
|
| ETP-46321 |
CS-2500 |
1252594-99-2 |
詳細(xì)
|
| CP-609754 (OSI754) |
CP-609754 |
1190094-64-4 |
詳細(xì)
|
| Fevipiprant |
非韋匹侖 |
872365-14-5 |
詳細(xì)
|
| UNC1215 |
UNC1215 |
1415800-43-9 |
詳細(xì)
|
| XL-147(SAR245408) |
XL147 |
956958-53-5 |
詳細(xì)
|
| CPI-637 |
(R)-4-甲基-6-(1-甲基-3-(1-甲基-1H-吡唑-4-基)-1H-吲唑-5-基)-4,5-二氫-1H-苯并[B][1,4]二氮雜-2(3H)-酮 |
1884712-47-3 |
詳細(xì)
|
| GBT-440 |
沃塞洛托 |
1446321-46-5 |
詳細(xì)
|
| AZD7986 |
AZD7986 |
1802148-05-5 |
詳細(xì)
|
| SRT-2104 |
?，斘髁?/td>
| 1093403-33-8 |
詳細(xì)
|
| NVS-PAK1-1 |
NVS-PAK1-1 |
1783816-74-9 |
詳細(xì)
|
| Binimetinib |
貝美替尼 |
606143-89-9 |
詳細(xì)
|
| STK16-IN-1 |
化合物STK16-IN-1 |
1223001-53-3 |
詳細(xì)
|
| 1-methyl-3-amino-4-cyanopyrazole |
1-甲基-3-氨基-4-氰基吡唑 |
21230-50-2 |
詳細(xì)
|
| EPZ-015938 (GSK3326595) |
GSK-3326595 |
1616392-22-3 |
詳細(xì)
|
| MKC-3946 |
1093119-54-0 |
1093119-54-0 |
詳細(xì)
|
| ORM-15341 |
ORM-15341 |
1297537-33-7 |
詳細(xì)
|
| UT-155 |
UT-155 |
2031161-35-8 |
詳細(xì)
|
| NIBR189 |
NIBR189 |
1599432-08-2 |
詳細(xì)
|
| MMAE |
一甲基澳瑞他汀E |
474645-27-7 |
詳細(xì)
|
| NNC 55-0396 |
NNC 55-0396 dihydrochloride |
357400-13-6 |
詳細(xì)
|
| 2-(2,6-dioxopiperidin-3-yl)-5-(4-(hydroxymethyl)piperidin-1-yl)isoindoline-1,3-dione |
2-(2,6-DIOXOPIPERIDIN-3-YL)-5-(4-(HYDROXYMETHYL)PIPERIDIN-1-YL)ISOINDOLINE-1,3-DIONE |
2229717-49-9 |
詳細(xì)
|
| Selgantolimod |
SELGANTOLIMOD |
2004677-13-6 |
詳細(xì)
|
| ONO-7475 |
ONO7475 |
1646839-59-9 |
詳細(xì)
|
| AB-928 |
3-(2-氨基-6-(1-((6-(2-羥丙基)吡啶-2-基)甲基)-1H-1,2,3-三唑-4-基)嘧啶-4-基)-2-甲基苯腈 |
2239273-34-6 |
詳細(xì)
|
| SPD304 |
CS-2594 |
869998-49-2 |
詳細(xì)
|
| Coumestrol |
香豆雌酚 |
479-13-0 |
詳細(xì)
|
| Ceapin-A7 |
N-(1-(2,4-雙(三氟甲基)芐基)-1H-吡唑-4-基)-5-(呋喃-2-基)異惡唑-3-甲酰胺 |
2323027-38-7 |
詳細(xì)
|
| Dexmedetomidine hydrochloride |
鹽酸右美托咪定 |
145108-58-3 |
詳細(xì)
|
| BS-181 HCl |
BS181 |
1397219-81-6 |
詳細(xì)
|
| NKP-1339 |
CS-2765 |
197723-00-5 |
詳細(xì)
|
| INF 4E |
Benzenepropanoic acid, 2-chloro-b-hydroxy-a-methylene-, ethyl ester |
88039-46-7 |
詳細(xì)
|
| (S)-1-amino-3-(3,4-dihydroisoquinolin-2(1H)-yl)propan-2-ol |
(S)-1-氨基-3-(3,4-二氫異喹啉-2(1H) - 基)丙-2-醇 |
1616077-51-0 |
詳細(xì)
|
| Ramelteon |
雷美替胺 |
196597-26-9 |
詳細(xì)
|
| AB-680 |
AB-680 |
2105904-82-1 |
詳細(xì)
|
| NCT-501 |
CS-2069 |
1802088-50-1 |
詳細(xì)
|
| Mitapivat |
PKR-IN-1 |
1260075-17-9 |
詳細(xì)
|
| 1-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)piperidine-4-carbaldehyde |
1-(2-(2,6-二氧哌啶-3-基)-1,3-二氧異吲哚啉-5-基)哌啶-4-甲醛 |
2241315-66-0 |
詳細(xì)
|
| NKY 80 |
化合物 T16333 |
299442-43-6 |
詳細(xì)
|
| Quetiapinehemifumaratesalt |
富馬酸喹硫平 |
111974-72-2 |
詳細(xì)
|
| Rucaparib(AG-014699) |
瑞卡帕布（AG-014699） |
459868-92-9 |
詳細(xì)
|
| ND-630 |
GS0976,ND-630 |
1434635-54-7 |
詳細(xì)
|
| DRV1 (GPR32) agonist C2A |
化合物 T33613 |
862811-76-5 |
詳細(xì)
|
| N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide |
PF-06747775 |
1776112-90-3 |
詳細(xì)
|
| Rucaparib |
瑞卡帕布 |
283173-50-2 |
詳細(xì)
|
| Kinase inhibitor 1 |
Kinase inhibitor-1 |
2135696-72-7 |
詳細(xì)
|
| 2'-deoxyinosine |
2'-脫氧肌苷 |
890-38-0 |
詳細(xì)
|
| 2'-Deoxycytidine |
2’-脫氧胞苷 |
951-77-9 |
詳細(xì)
|
| 2'-O-Methyluridine |
2'-甲氧基尿苷 |
2140-76-3 |
詳細(xì)
|
| 2'-OMe Cytidine |
2'-甲氧基胞苷 |
2140-72-9 |
詳細(xì)
|
| 2'-Fluoro-2'-deoxyuridine |
2'-氟-2'-脫氧尿苷 |
784-71-4 |
詳細(xì)
|
| 2'-Fluoro-2'-deoxyadenosine |
2'-氟-2'-脫氧腺苷 |
64183-27-3 |
詳細(xì)
|
| 2'-Fluoro-2'-Deoxycytidine |
2'-脫氧-2-氟胞苷 |
10212-20-1 |
詳細(xì)
|
| 2'-Deoxyadenosine monohydrate |
2'-脫氧腺苷一水合物 |
16373-93-6 |
詳細(xì)
|
| 2'-Deoxy-2'-fluoroguanosine |
2'-脫氧-2'-氟鳥(niǎo)苷 |
78842-13-4 |
詳細(xì)
|
| 2'-Deoxyuridine |
2-脫氧尿苷 |
951-78-0 |
詳細(xì)
|
| 2,6-diaminopurine 2'-deoxyriboside |
2,6-二氨基嘌呤-2'-脫氧核苷 |
4546-70-7 |
詳細(xì)
|
| Dansylsarcosine piperidiniuM salt |
丹酰肌氨酸哌啶鹽 |
72517-44-3 |
詳細(xì)
|
| 2,6-Dibromopyridine-4-carboxylic acid |
2,6-二溴吡啶-4-羧酸 |
2016-99-1 |
詳細(xì)
|
| 11H-Pyrrolo[2,1-c][1,4]benzodiazepin-11-one, 1,2,3,5,10,11a-hexahydro-, (11aR)- |
|
933981-46-5 |
詳細(xì)
|
| PFI-90 |
N'-(吡啶-2-基)吡啶-2-甲酰肼 |
53995-62-3 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 7-chloro-5,10-dihydro-, (11aS)- |
|
1581274-41-0 |
詳細(xì)
|
| Nω-Hydroxy-nor-L-Arginine Dihydrochloride |
NΩ-羥基或- L -精氨酸鹽酸鹽 |
291758-32-2 |
詳細(xì)
|
| 3-Methylenehexanoicacid |
3-亞甲基己酸 |
4380-89-6 |
詳細(xì)
|
| Afimoxifene |
阿非昔芬 |
68392-35-8 |
詳細(xì)
|
| DL-Sulforaphane |
蘿卜硫素 |
4478-93-7 |
詳細(xì)
|
| Erucin |
三芥子酸甘油酯 |
4430-36-8 |
詳細(xì)
|
| Pyrrolo[2,1-b]quinazoline-1-carboxylic acid, 1,2,3,9-tetrahydro-, (1S)- |
|
481710-98-9 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 7-chloro-5,10-dihydro-, (11aR)- |
|
1581274-42-1 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 7-bromo-5,10-dihydro-, (11aS)- |
|
1378239-53-2 |
詳細(xì)
|
| AG-7404 |
AG-7404 |
343565-99-1 |
詳細(xì)
|
| Fluorofurimazine |
6-(3-氨基-2-氟苯基)-8-(2-氟芐基)-2-(呋喃-2-基甲基)咪唑并[1,2-A]吡嗪-3(7H)-酮 |
2412089-96-2 |
詳細(xì)
|
| Pyrrolo[2,1-b]quinazoline-1-carboxylic acid, 1,2,3,9-tetrahydro-, (1R)- |
|
2220162-30-9 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 5,10-dihydro-, (11aS)- |
(S)-1,5,10,11A-四氫-3H-苯并[E]吡咯并[1,2-A][1,4]二氮雜卓-3,11(2H)-二酮 |
865430-51-9 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 5,10-dihydro-, (11aR)- |
(R)-1,5,10,11A-四氫-3H-苯并[E]吡咯并[1,2-A][1,4]二氮雜卓-3,11(2H)-二酮 |
2254419-02-6 |
詳細(xì)
|
| 1H-Pyrrolo[2,1-c][1,4]benzodiazepine-3,11(2H,11aH)-dione, 7-bromo-5,10-dihydro-, (11aR)- |
|
1581274-43-2 |
詳細(xì)
|
| 11H-Pyrrolo[2,1-c][1,4]benzodiazepin-11-one, 1,2,3,5,10,11a-hexahydro-, (11aS)- |
|
55661-84-2 |
詳細(xì)
|
| Florfenicol Impurity 2 |
氟苯尼考雜質(zhì)2 |
2293206-33-2 |
詳細(xì)
|
| 2'-Deoxy-2'-fluoroinosine |
2'-脫氧-2'-氟肌苷 |
80049-87-2 |
詳細(xì)
|
| Rezivertinib(BPI-7711) |
REZIVERTINIB |
1835667-12-3 |
詳細(xì)
|